Nicole A. Sherry

Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients.

P. Raskin, L. Dimeglio, E. Tsalikian, 2015, The Journal of clinical investigation.

Teplizumab Preserves C-Peptide in Recent-Onset Type 1 Diabetes

K. Herold, E. Bonvini, William Hagopian, 2013, Diabetes.